Mitochondrial Dysfunction in Neurodegenerative Diseases

被引:976
作者
Johri, Ashu
Beal, M. Flint [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
TRANSGENIC MOUSE MODEL; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; ALZHEIMERS-DISEASE; DNA DELETIONS; AMYLOID-BETA; PGC-1-ALPHA; PARKINSONS; PROTECTS; SIRT1;
D O I
10.1124/jpet.112.192138
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neurodegenerative diseases are a large group of disabling disorders of the nervous system, characterized by the relative selective death of neuronal subtypes. In most cases, there is overwhelming evidence of impaired mitochondrial function as a causative factor in these diseases. More recently, evidence has emerged for impaired mitochondrial dynamics (shape, size, fission-fusion, distribution, movement etc.) in neurodegenerative diseases such as Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. Here, we provide a concise overview of the major findings in recent years highlighting the importance of healthy mitochondria for a healthy neuron.
引用
收藏
页码:619 / 630
页数:12
相关论文
共 99 条
  • [1] Beal M Flint, 2007, Novartis Found Symp, V287, P183
  • [2] Neuroprotective effects of creatine
    Beal, M. Flint
    [J]. AMINO ACIDS, 2011, 40 (05) : 1305 - 1313
  • [3] Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
    Beal, M. Flint
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S189 - S194
  • [4] Mitochondria take center stage in aging and neurodegeneration
    Beal, MF
    [J]. ANNALS OF NEUROLOGY, 2005, 58 (04) : 495 - 505
  • [5] BEAL MF, 1993, J NEUROSCI, V13, P4181
  • [6] High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
    Bender, A
    Krishnan, KJ
    Morris, CM
    Taylor, GA
    Reeve, AK
    Perry, RH
    Jaros, E
    Hersheson, JS
    Betts, J
    Klopstock, T
    Taylor, RW
    Turnbull, DM
    [J]. NATURE GENETICS, 2006, 38 (05) : 515 - 517
  • [7] Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions
    Bender, Andreas
    Schwarzkopf, Rachel-Maria
    McMillan, Anja
    Krishnan, Kim J.
    Rieder, Gabriele
    Neumann, Manuela
    Elstner, Matthias
    Turnbull, Douglas M.
    Klopstock, Thomas
    [J]. JOURNAL OF NEUROLOGY, 2008, 255 (08) : 1231 - 1235
  • [8] Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease
    Bosetti, F
    Brizzi, F
    Barogi, S
    Mancuso, M
    Siciliano, G
    Tendi, EA
    Murri, L
    Rapoport, SI
    Solaini, G
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (03) : 371 - 376
  • [9] Mutant huntingtin and mitochondrial dysfunction
    Bossy-Wetzel, Ella
    Petrilli, Alejandra
    Knott, Andrew B.
    [J]. TRENDS IN NEUROSCIENCES, 2008, 31 (12) : 609 - 616
  • [10] The energetics of Huntington's disease
    Browne, SE
    Beal, MF
    [J]. NEUROCHEMICAL RESEARCH, 2004, 29 (03) : 531 - 546